The enterprise research app shows that recently, Chongqing Yudu Biotech Pilot Private Equity Investment Fund partnership was established with an investment amount of 300 million yuan. The scope of business includes equity investment using private equity funds. According to enterprise research and equity penetration, the partnership was jointly funded by Haoyuan Pharmaceutical Investment Co., Ltd., a wholly-owned subsidiary of Haoyuan Pharmaceutical, and a Chongqing Industrial Investment Parent Fund partnership.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.